Aesthetic medicine products. Life science ingredients distributor Barentz acquires majority stake in India’s Gangwal Chemicals 

Derma filler

THE WHAT Life science ingredients distributor Barentz has announced an agreement to acquire a majority stake in the distribution functions of India-based Gangwal Chemicals.

THE DETAILS A high-end distributor and specialty solutions provider based in Mumbai, Gangwal Chemicals is said to have a leading position in pharmaceuticals, focusing on speciality, nutraceuticals and cosmetics ingredients.

The acquisition is said to strengthen Barentz’ footprint in the pharma excipient distribution market and increases its geographic exposure in the Asia-Pacific region. 

Fat dissolving

Gangwal Founder, Anil Jain will continue to lead the company following the acquisition, which is subject to regulatory closing conditions. 

THE WHY The buy-out has been cited as an ‘important step’ in Barentz’ strategy to become a leading global specialty pharmaceutical and nutraceutical active ingredient distributor.’

Hidde van der Wal, CEO of Barentz, said, ‘‘We have been keen to enter the Indian market for a long time. In Gangwal, we found the right partner due to the similarities in how we do business. We are extremely impressed by the way the Gangwal team has developed the business and the long-term relationships they have built with different global excipient producers. 

“This platform gives us a great leadership team and many opportunities to create new business initiatives to support our global network of suppliers. We are looking forward to accelerating Gangwal’s future strategic growth.”

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

  Aesthetic medicine products. Sephora publishes guidelines to safeguard social media users

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.